1Markel A,Manzo RA,Strandness DE.The potential role of thrombolytic therapy in venous thrombosis[J].Arch Intern Med,1992,152(6):1265-1267
2Hull RD,Raskob GE,Rosenbloom D,et al.Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis[J].N Engl J Med,1990,322(18):1260-1264
3Strandness DE,Langlois Y,Cramer M,et al.Long-term sequelae of acute venous thrombosis[J].JAMA,1983,250(10):1289-1292
4Comerota AJ,Throm RC,Mathias SD,et al.Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life[J].J Vasc Surg,2000,32(1):130-137
1Gould MK, Dembitzer AD, Doyle RL, et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. Ann Intern Med, 1999, 130:800-808.
2Hirsh J, Warkentin TE, Shaughnessy SG. et al. Heparin and lowmolecular-weight heparin : mechanisms of action, pharmacokinetics,dosing, monitoring, efficacy, and safety. Chest, 2001, 119:64-94.
3Hirsh J, Lee AY. How we diagnose and treat deep vein thrombosis.Blood, 2002, 99:3102-3110.
4Weitz JI. Low-molecular-weight heparins. N Engl J Med, 1997,337:688-698.
6Levine MN, Raskob CG, Landefeld S, et al. Hemorrhagic complications of anticoagutant treatment. Chest, 2001, 119 : 108-121.
7Agnelli G, Prandoni P,Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis, Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med, 2001, 345 : 165-169.
8Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med,2001, 161:2105-2109.
9Brenner B. Inherited thrombophilia and fetal loss. Curt Opin Hematol, 2000, 7:290-295.
